| Cell subset . | % tetramer+ CD8+ T cells staining4-150 . | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 575 . | 3KI . | IPI . | 297 . | |||||||||||||||||
| LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | |
| CD11a+ | 98 | 99 | 99 | 96 | NT4-151 | 99 | 99 | 100 | 99 | NT | 99 | 99 | 99 | 99 | 96 | 99 | 99 | NT | 98 | 99 |
| CD28+ | 38 | 16 | 12 | 33 | NT | 58 | 38 | 28 | 59 | NT | 80 | 50 | 45 | 70 | 63 | 80 | 58 | 18 | 68 | 90 |
| CD45RA+ | 15 | 10 | 9.5 | NT | NT | 13 | 15 | 14 | 14 | NT | 14 | 8.7 | 5.0 | 6.6 | 5.1 | 15 | 28 | 10 | 25 | 10 |
| CD49d+ | 96 | 97 | 95 | NT | NT | 95 | 97 | 93 | 95 | NT | 97 | 99 | 99 | 98 | 99 | 97 | 95 | NT | NT | 99 |
| CD62L+ | 22 | 5.1 | 5.8 | NT | NT | 11 | 5.1 | 3.4 | 10 | NT | 8.5 | 4.4 | 3.0 | 7.6 | 24 | 14 | 7.7 | 7.2 | 10 | 20 |
| CD95+ | 98 | 99 | 99 | NT | NT | 98 | 99 | 98 | 99 | NT | 99 | 99 | 99 | 99 | 97 | 99 | 97 | NT | 95 | 97 |
| MHC class II DR+ | 83 | 96 | 76 | NT | NT | 91 | 95 | 92 | 95 | NT | 91 | 90 | 79 | 85 | 82 | 87 | 95 | 92 | 92 | 80 |
| Cell subset . | % tetramer+ CD8+ T cells staining4-150 . | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 575 . | 3KI . | IPI . | 297 . | |||||||||||||||||
| LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | LNs . | Sp . | BM . | Ton . | Thy . | |
| CD11a+ | 98 | 99 | 99 | 96 | NT4-151 | 99 | 99 | 100 | 99 | NT | 99 | 99 | 99 | 99 | 96 | 99 | 99 | NT | 98 | 99 |
| CD28+ | 38 | 16 | 12 | 33 | NT | 58 | 38 | 28 | 59 | NT | 80 | 50 | 45 | 70 | 63 | 80 | 58 | 18 | 68 | 90 |
| CD45RA+ | 15 | 10 | 9.5 | NT | NT | 13 | 15 | 14 | 14 | NT | 14 | 8.7 | 5.0 | 6.6 | 5.1 | 15 | 28 | 10 | 25 | 10 |
| CD49d+ | 96 | 97 | 95 | NT | NT | 95 | 97 | 93 | 95 | NT | 97 | 99 | 99 | 98 | 99 | 97 | 95 | NT | NT | 99 |
| CD62L+ | 22 | 5.1 | 5.8 | NT | NT | 11 | 5.1 | 3.4 | 10 | NT | 8.5 | 4.4 | 3.0 | 7.6 | 24 | 14 | 7.7 | 7.2 | 10 | 20 |
| CD95+ | 98 | 99 | 99 | NT | NT | 98 | 99 | 98 | 99 | NT | 99 | 99 | 99 | 99 | 97 | 99 | 97 | NT | 95 | 97 |
| MHC class II DR+ | 83 | 96 | 76 | NT | NT | 91 | 95 | 92 | 95 | NT | 91 | 90 | 79 | 85 | 82 | 87 | 95 | 92 | 92 | 80 |
Values represent the percentages of the Mamu-A*01+/p11C, C-M complex population staining for expression of CD11a, CD28, CD45RA, CD49d, CD62L, CD95, and MHC class II-DR in lymph nodes (LNs) [median of % in lymph nodes that were sampled simultaneously (mandibular, axillary, inguinal, mesenteric, iliac)], spleen (Sp), bone marrow (BM), tonsil (Ton), and thymus (Thy) gated on CD8+ T cells. CD8+ T cells are defined by gating on CD8αβ+ CD3+ cells.
NT, not tested.